Heparin induced thrombocytopenia antibodies in Covid‐19
暂无分享,去创建一个
D. Neuberg | W. Aird | J. Zwicker | K. Bauer | R. Joyce | R. Patell | Adeela Khan | Thomas Bogue | P. Bindal | Anita Koshy | Mwanasha H Merrill | Anita G Koshy
[1] D. Leaf,et al. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection , 2020, Blood.
[2] V. Fuster,et al. Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19 , 2020, Journal of the American College of Cardiology.
[3] E. Andrès,et al. Immune Thrombocytopenic Purpura in a Patient with Covid-19 , 2020, The New England journal of medicine.
[4] Xiaowei Yan,et al. Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19 , 2020, The New England journal of medicine.
[5] S. Berentsen. New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia , 2020, Frontiers in Immunology.
[6] T. Warkentin,et al. Performance characteristics of an automated latex immunoturbidimetric assay [HemosIL® HIT-Ab(PF4-H)] for the diagnosis of immune heparin-induced thrombocytopenia. , 2017, Thrombosis research.
[7] C. Francis,et al. Heparin induced thrombocytopenia and thrombosis in a tertiary care hospital. , 2009, Thrombosis research.
[8] J. Mattson,et al. The incidence of recognized heparin-induced thrombocytopenia in a large, tertiary care teaching hospital. , 2007, Chest.